Effectiveness of Electroacupuncture in the Treatment of Diabetic Peripheral Neuropathy

NANot yet recruitingINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

October 31, 2023

Primary Completion Date

June 1, 2025

Study Completion Date

December 31, 2025

Conditions
Diabetic Peripheral Neuropathic Pain
Interventions
PROCEDURE

Basal therapy+EA

"1. Participants are not set up with uniform medication. High blood sugar is controlled by hypoglycaemic drugs, patients with hypertension and hyperlipidaemia can take antihypertensive and lipid-lowering drugs, while other drugs are based on the patient's current medication.~2. Main acupoints: Qihai (RN6), Guanyuan (RN4), Xuehai (SP10), Yanglingquan (GB34), Zusanli (T36), Yinlingquan (SP9), Sanyinjiao (SP6), Xuanzhong (GB39), Jiexi (ST41), Zulinqi (GB41), Taichong (SP41). Supporting acupoints: for pain in the upper limbs, add Baxie, Quchi (LI11), Shousanli (LI10), Hegu (LI4), and Ashixue; for pain in the lower limbs, add Bafeng, Neiting (ST44),Kunlun (BL60). Operation: Acupuncture needles of size 25\*40mm will be used. The electrode will be connected Yanglingquan (GB34) and Sanyinjiao (SP6), electrode wire will be connected to the electro-acupuncture apparatus using continuous wave with a frequency of 2Hz at an intensity suitable for the comfort of the subject."

OTHER

Basal therapy

Participants are not set up with uniform medication. High blood sugar is controlled by hypoglycaemic drugs, patients with hypertension and hyperlipidaemia can take antihypertensive and lipid-lowering drugs, while other drugs are based on the patient's current medication.

Trial Locations (1)

Unknown

the Third affiliated hospital of Zhejiang Chinese Medical university, Hangzhou

All Listed Sponsors
collaborator

The First Affiliated Hospital of Zhejiang Chinese Medical University

OTHER

collaborator

The Second Affiliated Hospital of Zhejiang Chinese Medical University

OTHER

lead

Zhejiang Chinese Medical University

OTHER_GOV

NCT06054087 - Effectiveness of Electroacupuncture in the Treatment of Diabetic Peripheral Neuropathy | Biotech Hunter | Biotech Hunter